IGF-1 reverses the osteogenic inhibitory effect of dexamethasone on BMP9-induced osteogenic differentiation in mouse embryonic fibroblasts via PI3K/AKT/COX-2 pathway
This study may provide new clinical management strategy for GIOP cases.
Source: The Journal of Steroid Biochemistry and Molecular Biology - Category: Biochemistry Source Type: research
More News: Biochemistry | Biology | Dexamethasone | Insulin | Molecular Biology | Orthopaedics | Osteoporosis | Prednisone | Stem Cell Therapy | Stem Cells | Study